MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive behavioural thrapy and adiunctive physical therapy for functional movement disorders

R. Erro, M. Tinazzi, C. Dallocchio (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 2079

Keywords: Psychogenic movement disorders(PMD): Treatment

Session Information

Date: Thursday, June 23, 2016

Session Title: Clinical trials and therapy in movement disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To test the feasibility and efficacy of Cognitive Behavioural Therapy (CBT) and Adjunctive Physical Therapy (APA) APA in Functional Movement Disorders (FMD).

Background: Functional Movement Disorders are one of the commonest functional neurological disorder (FND) seen in outpatient and inpatient settings, thus having a remarkable impact on the health care system. Nonetheless, there are no treatment recommendations and their prognosis is variable, yet generally unfavorable.

Methods: Twenty-nine patients with FMD (Conversion Disorder according to the DSM-5) were randomized to receive CBT alone (90min-session, once a week) or CBT+APA (60min-session, twice a week). Both treatments ran for 12 weeks. Patients were assessed at baseline (T0) and at the end of the 12-week program (T1). All subjects were videotaped at T0 and T1 using the Psychogenic Movement Disorder Rating Scale (PMDRS). A single rater (RE), blinded to the aims of the study and time evaluation (e.g., T0, T1) completed the PMDRS on videotapes, in a randomized order. PMDRS represented the primary outcome. Secondary outcomes included the Hamilton depression scale (HDS), the Beck anxiety inventory (BAI), and the Patient Heath Questionnaire-15 (PHQ-15).

Results: Eight patients (27.6%) withdrew their consent. Hence, 21 patients were included in the current report (11 CBT alone; 10 CBT+APA). ANOVA tests for repeated measures showed a significant improvement of the primary outcome and all secondary outcomes over time (all, p<0.001) with no difference between groups (all, p>0.05).Higher motor severity at baseline (p=0.045) and longer disease duration (p=0.043) were significantly associated with a poorer outcome (R2=0.45; p<0.005).

Conclusions: Both groups significantly improved over time, with no difference between the two of them. This indicates that CBT is feasible (compliance over 70%) and effective in improving the specific motor symptoms in patients with FMD. CBT was also effective in ameliorating depressive symptoms and anxiety, in line with previous results. However, the improvement in the primary outcome (e.g., the specific motor disorder) was not directly driven by the amelioration of affective symptoms.

To cite this abstract in AMA style:

R. Erro, M. Tinazzi, C. Dallocchio. Cognitive behavioural thrapy and adiunctive physical therapy for functional movement disorders [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-behavioural-thrapy-and-adiunctive-physical-therapy-for-functional-movement-disorders/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-behavioural-thrapy-and-adiunctive-physical-therapy-for-functional-movement-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley